Found: 7
Select item for more details and to access through your institution.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00268-w
- By:
- Publication type:
- Article
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00230-2
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00192-5
- By:
- Publication type:
- Article
Synthesis of [<sup>18</sup>F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00190-7
- By:
- Publication type:
- Article
The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 20, doi. 10.1007/s00259-023-06472-1
- By:
- Publication type:
- Article
EANM guideline on quality risk management for radiopharmaceuticals.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3353, doi. 10.1007/s00259-022-05738-4
- By:
- Publication type:
- Article
EANM position on the in-house preparation of radiopharmaceuticals.
- Published in:
- 2022
- By:
- Publication type:
- Editorial